Nusayba Bagegni, MD
Nusayba Bagegni, MD, is Assistant Professor in the Department of Medicine, Division of Oncology, at Washington University School of Medicine in St. Louis. She is an Associate Member of Siteman Cancer Center. Dr. Bagegni specializes in the treatment of patients with breast cancer. Dr. Bagegni earned her medical degree with research distinction from the University of Iowa Carver College of Medicine. She completed a residency in Internal Medicine at Barnes-Jewish Hospital. While at Washington University School of Medicine, she went on to complete a fellowship in hematology/oncology, serving as Chief Fellow, where she received the Hanna Jean Khoury Outstanding Graduate Award. Dr. Bagegni is board-certified in internal medicine, medical oncology, and hematology. Dr. Bagegni has research interests focused in breast cancer clinical trials, developmental therapeutics and trainee education. She received the Washington University Hematology/Oncology Fellowship Program 2021 Teacher of the Year Award. She serves as a Principal Investigator for several clinical trials and is a member of the Siteman Cancer Center Protocol Review and Monitoring Committee. Dr. Bagegni is a member of ASCO and AACR. She is a member for the NCCN Anti-emesis Guidelines Panel. She is breast cancer committee member for Alliance, HCRN and ACCRU, as well as the Siteman Cancer Center Breast Cancer Equity Group.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Aptitude HealthDate added:02/21/2024Date updated:04/01/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:OncliveDate added:02/21/2024Date updated:04/01/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:NCCNDate added:02/21/2024Date updated:04/01/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Curio ScienceDate added:02/21/2024Date updated:04/01/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:MJH LifeSciencesDate added:02/21/2024Date updated:04/01/2025
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:NovartisDate added:02/21/2024Date updated:04/01/2025
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:Sermonix Pharmaceuticals LLCDate added:02/21/2024Date updated:04/01/2025
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:Biovica InternationalDate added:02/21/2024Date updated:04/01/2025
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:PfizerDate added:02/21/2024Date updated:04/01/2025
-
Attribution:OtherType of financial relationship:Grant Or ContractIneligible company:AstraZenecaDate added:02/21/2024Date updated:04/01/2025